Kirandeep Kaur, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kaur’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A109727 · Current
Licensed to practise in California · since 2009 · expires 2027-03-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$12,511
Medicare paid this office $12,511 for 142 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient problem focused exam of visual system | 103 | $4,461 | $32 |
| Imaging of optic nerve | 75 | $1,311 | $17 |
| Established patient complete exam of visual system | 14 | $909 | $65 |
| Imaging of retina | 38 | $674 | $17 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
142 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 11% · Women 64% · Also on Medicaid 85% · Health risk score 1.35. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 59% · Chronic kidney disease 20% · Coronary heart disease 17% · Heart failure 14% · Atrial fibrillation 14% · Depression 14% · Cancer 12%.
The office billed $190,188, Medicare allowed $19,905 and paid $12,511; for 335 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 142 | 335 | 73 | 1.35 | $190,188 | $12,511 |
| 2023 | 177 | 478 | 73 | 1.37 | $243,671 | $16,021 |
| 2022 | 205 | 568 | 73 | 1.42 | $274,329 | $18,337 |
| 2021 | 202 | 561 | 72 | 1.44 | $274,187 | $19,972 |
| 2020 | 226 | 617 | 71 | 1.39 | $273,963 | $20,747 |
| 2019 | 266 | 787 | 71 | 1.46 | $371,538 | $33,113 |
| 2018 | 11 | 14 | 69 | 0.99 | $6,060 | $810 |
| 2017 | 18 | 31 | 71 | 1.68 | $6,410 | $1,507 |
| 2016 | 12 | 19 | 74 | 0.72 | $6,978 | $1,215 |
| 2014 | 14 | 19 | 69 | 1.91 | $3,357 | $596 |
| 2013 | 17 | 29 | 74 | 1.23 | $4,682 | $906 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Established patient problem focused exam of visual system | 136 | $6,766 | $36 |
| Imaging of optic nerve | 89 | $1,263 | $14 |
| Exam of visual field with extended testing | 55 | $1,056 | $18 |
| Imaging of retina | 40 | $884 | $20 |
| Established patient complete exam of visual system | 18 | $727 | $40 |
| New patient problem focused exam of visual system | 18 | $478 | $27 |
| Exam of the internal drainage system of eye | 20 | $255 | $13 |
| Ultrasound scan of cornea to determine thickness | 16 | $88 | $6 |
2022: 7 services
| Established patient problem focused exam of visual system | 164 | $6,989 | $33 |
| Established patient complete exam of visual system | 33 | $1,700 | $52 |
| Exam of visual field with extended testing | 77 | $1,430 | $18 |
| Imaging of optic nerve | 94 | $1,231 | $13 |
| Imaging of retina | 58 | $1,056 | $18 |
| Exam of the internal drainage system of eye | 31 | $463 | $14 |
| Ultrasound scan of cornea to determine thickness | 23 | $119 | $5 |
2021: 7 services
| Established patient problem focused exam of visual system | 171 | $8,647 | $35 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 12 | $5,047 | $229 |
| Imaging of optic nerve | 88 | $1,268 | $14 |
| Exam of visual field with extended testing | 68 | $1,116 | $16 |
| Exam of the internal drainage system of eye | 34 | $651 | $18 |
| Imaging of retina | 45 | $603 | $13 |
| Ultrasound scan of cornea to determine thickness | 24 | $174 | $7 |
2020: 8 services
| Established patient problem focused exam of visual system | 180 | $9,387 | $37 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 14 | $5,307 | $212 |
| Imaging of optic nerve | 101 | $1,387 | $14 |
| Exam of visual field with extended testing | 61 | $1,007 | $16 |
| Imaging of retina | 37 | $871 | $22 |
| Telephone medical discussion with physician, 5-10 minutes | 49 | $859 | $17 |
| Exam of the internal drainage system of eye | 34 | $467 | $14 |
| Ultrasound scan of cornea to determine thickness | 31 | $156 | $5 |
2019: 7 services
| Established patient problem focused exam of visual system | 218 | $13,600 | $42 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $6,810 | $227 |
| Exam of visual field with extended testing | 106 | $2,684 | $24 |
| Imaging of optic nerve | 131 | $2,413 | $18 |
| Exam of the internal drainage system of eye | 71 | $1,449 | $18 |
| Imaging of retina | 31 | $652 | $21 |
| Ultrasound scan of cornea to determine thickness | 37 | $254 | $7 |
2017: 1 service
| Established patient problem focused exam of visual system | 17 | $1,158 | $46 |
2016: 1 service
| Established patient problem focused exam of visual system | 11 | $492 | $35 |
2014: 1 service
| Established patient problem focused exam of visual system | 12 | $437 | $36 |
Medicaid work
$7,593 in 2024
Medicaid paid $7,593 for 1,217 billed services this clinician did in 2024, up to 68 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 570 | $3,869 |
| INTRM OPH EXAM NEW PATIENT | 142 | $1,526 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 354 | $1,460 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 100 | $476 |
| GONIOSCOPY | 39 | $219 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 12 | $44 |
| 2024 | 1,217 | 6 | 68 | $7,593 |
| 2023 | 1,914 | 7 | 88 | $11,527 |
| 2022 | 1,442 | 7 | 77 | $9,495 |
| 2021 | 726 | 5 | 54 | $2,792 |
| 2020 | 864 | 5 | 62 | $5,557 |
| 2019 | 1,398 | 6 | 82 | $6,971 |
| 2018 | 418 | 6 | 40 | $3,179 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 814 | $5,776 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 410 | $1,858 |
| INTRM OPH EXAM NEW PATIENT | 145 | $1,609 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 259 | $1,224 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 149 | $620 |
| GONIOSCOPY | 120 | $392 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 17 | $47 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 753 | $6,483 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 264 | $1,142 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 219 | $994 |
| GONIOSCOPY | 92 | $291 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 37 | $290 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 59 | $287 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 18 | $8 |
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 233 | $1,228 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 249 | $816 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 183 | $554 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 13 | $104 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 48 | $90 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 501 | $3,965 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 198 | $825 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 126 | $666 |
| GONIOSCOPY | 26 | $65 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 13 | $35 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 719 | $4,624 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 282 | $1,047 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 239 | $875 |
| GONIOSCOPY | 125 | $338 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 20 | $55 |
| INTRM OPH EXAM NEW PATIENT | 13 | $32 |
2018
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 214 | $1,759 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 60 | $686 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 67 | $320 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 48 | $289 |
| INTRM OPH EXAM NEW PATIENT | 14 | $91 |
| GONIOSCOPY | 15 | $33 |
Drugs they prescribed that Part D paid
$76,740
Pharmacies billed $76,740 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,574) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,286 generic and 288 brand-name prescriptions · $76,740 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 94 | $29,631 | $315 |
| Cyclosporine | 36 | $10,771 | $299 |
| Latanoprost | 859 | $7,270 | $8 |
| Rhopressa | 20 | $6,819 | $341 |
| Brimonidine | 100 | $5,417 | $54 |
See all 12 drugs
| Lumigan | 94 | $29,631 | $315 |
| Cyclosporine | 36 | $10,771 | $299 |
| Latanoprost | 859 | $7,270 | $8 |
| Rhopressa | 20 | $6,819 | $341 |
| Brimonidine | 100 | $5,417 | $54 |
| Simbrinza | 11 | $3,082 | $280 |
| Timolol Maleate | 186 | $2,770 | $15 |
| Brinzolamide | 11 | $1,640 | $149 |
| Travoprost | 15 | $1,494 | $100 |
| Dorzolamide | 91 | $1,411 | $16 |
| Dorzolamide-Timolol | 87 | $1,292 | $15 |
| Prednisolone Acetate | 25 | $1,015 | $41 |
Year by year
| 2024 | 1,574 | 230 | 0% (0) | 18% | $76,740 |
| 2023 | 1,355 | 231 | 0% (0) | 22% | $93,302 |
| 2022 | 1,199 | 208 | 0% (0) | 25% | $75,263 |
| 2021 | 988 | 174 | 0% (0) | 26% | $65,848 |
| 2020 | 784 | 147 | 0% (0) | 23% | $38,748 |
| 2019 | 749 | 229 | 0% (0) | 24% | $46,894 |
| 2018 | 885 | 303 | 0% (0) | 15% | $47,279 |
| 2017 | 1,336 | 416 | 0% (0) | 13% | $63,406 |
| 2016 | 1,459 | 454 | 0% (0) | 15% | $72,574 |
| 2015 | 1,283 | 445 | None | 18% | $58,744 |
| 2014 | 1,272 | 437 | None | 18% | $58,060 |
| 2013 | 669 | 312 | None | 25% | $28,518 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Lumigan | 58 | $22,523 | $388 |
| Restasis | 15 | $9,963 | $664 |
| Latanoprost | 685 | $9,788 | $14 |
| Cyclosporine | 22 | $8,176 | $372 |
| Alphagan P | 12 | $6,594 | $549 |
| Brimonidine | 67 | $6,190 | $92 |
| Eliquis | 18 | $5,040 | $280 |
| Rhopressa | 12 | $4,198 | $350 |
| Timolol Maleate | 159 | $3,568 | $22 |
| Brinzolamide | 11 | $3,025 | $275 |
| Travoprost | 19 | $2,475 | $130 |
| Dorzolamide | 79 | $2,397 | $30 |
| Dorzolamide-Timolol | 62 | $1,369 | $22 |
| Prednisolone Acetate | 30 | $1,252 | $42 |
| Olopatadine | 11 | $240 | $22 |
| Erythromycin | 12 | $140 | $12 |
2022: 12 drugs
| Lumigan | 55 | $19,217 | $349 |
| Restasis | 37 | $13,550 | $366 |
| Latanoprost | 580 | $9,095 | $16 |
| Alphagan P | 16 | $7,207 | $450 |
| Travoprost | 17 | $5,088 | $299 |
| Brimonidine | 77 | $4,514 | $59 |
| Timolol Maleate | 188 | $3,318 | $18 |
| Brinzolamide | 11 | $3,114 | $283 |
| Dorzolamide | 71 | $2,061 | $29 |
| Prednisolone Acetate | 31 | $1,061 | $34 |
| Dorzolamide-Timolol | 52 | $931 | $18 |
| Erythromycin | 15 | $188 | $13 |
2021: 11 drugs
| Lumigan | 39 | $16,121 | $413 |
| Restasis | 30 | $10,292 | $343 |
| Alphagan P | 28 | $8,435 | $301 |
| Brimonidine | 45 | $6,962 | $155 |
| Latanoprost | 465 | $6,488 | $14 |
| Travoprost | 19 | $6,134 | $323 |
| Timolol Maleate | 160 | $2,720 | $17 |
| Dorzolamide | 82 | $1,883 | $23 |
| Prednisolone Acetate | 25 | $1,055 | $42 |
| Dorzolamide-Timolol | 33 | $630 | $19 |
| Doxycycline Monohydrate | 11 | $344 | $31 |
2020: 11 drugs
| Brimonidine | 34 | $6,432 | $189 |
| Latanoprost | 412 | $5,734 | $14 |
| Restasis | 11 | $5,131 | $466 |
| Azopt | 11 | $3,621 | $329 |
| Alphagan P | 18 | $3,307 | $184 |
| Travoprost | 15 | $2,770 | $185 |
| Travatan Z | 13 | $2,615 | $201 |
| Dorzolamide | 68 | $1,587 | $23 |
| Timolol Maleate | 108 | $1,062 | $10 |
| Prednisolone Acetate | 21 | $1,004 | $48 |
| Azelastine | 12 | $172 | $14 |
2019: 10 drugs
| Restasis | 15 | $6,783 | $452 |
| Travatan Z | 24 | $6,445 | $269 |
| Latanoprost | 358 | $5,090 | $14 |
| Brimonidine | 53 | $4,829 | $91 |
| Azopt | 13 | $4,354 | $335 |
| Prednisolone Acetate | 43 | $2,096 | $49 |
| Timolol Maleate | 90 | $1,063 | $12 |
| Dorzolamide-Timolol | 21 | $817 | $39 |
| Dorzolamide | 34 | $773 | $23 |
| Erythromycin | 13 | $177 | $14 |
2018: 10 drugs
| Latanoprost | 400 | $9,532 | $24 |
| Lumigan | 16 | $7,721 | $483 |
| Dorzolamide-Timolol | 102 | $2,411 | $24 |
| Brimonidine | 65 | $2,083 | $32 |
| Prednisolone Acetate | 30 | $1,834 | $61 |
| Timolol Maleate | 91 | $1,369 | $15 |
| Valacyclovir | 11 | $1,021 | $93 |
| Dorzolamide | 36 | $883 | $25 |
| Erythromycin | 17 | $258 | $15 |
| Levobunolol | 19 | $244 | $13 |
2017: 15 drugs
| Latanoprost | 493 | $11,942 | $24 |
| Lumigan | 23 | $8,153 | $354 |
| Restasis | 15 | $7,168 | $478 |
| Travatan Z | 11 | $4,793 | $436 |
| Dorzolamide-Timolol | 152 | $4,060 | $27 |
| Prednisolone Acetate | 57 | $3,965 | $70 |
| Timolol Maleate | 193 | $2,878 | $15 |
| Combigan | 13 | $2,291 | $176 |
| Brimonidine | 94 | $2,077 | $22 |
| Dorzolamide | 59 | $1,378 | $23 |
| Erythromycin | 67 | $1,147 | $17 |
| Valacyclovir | 13 | $1,083 | $83 |
| Levobunolol | 24 | $296 | $12 |
| Olopatadine | 13 | $292 | $22 |
| Ofloxacin | 12 | $260 | $22 |
2016: 17 drugs
| Latanoprost | 516 | $11,663 | $23 |
| Timoptic Ocudose | 15 | $9,576 | $638 |
| Lumigan | 31 | $9,435 | $304 |
| Travatan Z | 13 | $4,861 | $374 |
| Timolol Maleate | 217 | $3,334 | $15 |
| Brimonidine | 91 | $3,181 | $35 |
| Dorzolamide-Timolol | 111 | $3,173 | $29 |
| Prednisolone Acetate | 38 | $2,590 | $68 |
| Combigan | 12 | $1,903 | $159 |
| Erythromycin | 96 | $1,670 | $17 |
| Dorzolamide | 72 | $1,646 | $23 |
| Valacyclovir | 18 | $1,383 | $77 |
| Fluorometholone | 12 | $908 | $76 |
| Neomycin-Polymyxin-Dexameth | 22 | $420 | $19 |
| Levobunolol | 27 | $332 | $12 |
| Cephalexin | 11 | $172 | $16 |
| Furosemide | 24 | $108 | $5 |
2015: 19 drugs
| Latanoprost | 469 | $10,530 | $22 |
| Lumigan | 34 | $9,637 | $283 |
| Restasis | 16 | $6,790 | $424 |
| Travatan Z | 17 | $4,555 | $268 |
| Prednisolone Acetate | 65 | $4,423 | $68 |
| Timolol Maleate | 161 | $2,279 | $14 |
| Erythromycin | 98 | $1,736 | $18 |
| Combigan | 11 | $1,560 | $142 |
| Brimonidine | 61 | $1,465 | $24 |
| Valacyclovir | 15 | $1,305 | $87 |
| Dorzolamide | 61 | $1,152 | $19 |
| Zymaxid | 12 | $906 | $76 |
| Acyclovir | 16 | $881 | $55 |
| Neomycin-Polymyxin-Dexameth | 44 | $805 | $18 |
| Dorzolamide-Timolol | 31 | $639 | $21 |
| Levobunolol | 34 | $381 | $11 |
| Fluorometholone | 11 | $342 | $31 |
| Diclofenac | 11 | $199 | $18 |
| Ofloxacin | 15 | $125 | $8 |
2014: 15 drugs
| Latanoprost | 393 | $8,788 | $22 |
| Lumigan | 21 | $8,520 | $406 |
| Restasis | 14 | $5,231 | $374 |
| Travatan Z | 23 | $5,149 | $224 |
| Prednisolone Acetate | 57 | $4,208 | $74 |
| Timolol Maleate | 193 | $3,363 | $17 |
| Dorzolamide-Timolol | 75 | $2,240 | $30 |
| Brimonidine | 82 | $1,621 | $20 |
| Dorzolamide | 69 | $1,603 | $23 |
| Erythromycin | 76 | $1,497 | $20 |
| Combigan | 11 | $1,393 | $127 |
| Neomycin-Polymyxin-Dexameth | 65 | $1,185 | $18 |
| Levobunolol | 44 | $545 | $12 |
| Acyclovir | 12 | $408 | $34 |
| Ofloxacin | 17 | $145 | $9 |
2013: 14 drugs
| Latanoprost | 121 | $2,819 | $23 |
| Travatan Z | 11 | $2,048 | $186 |
| Prednisolone Acetate | 49 | $1,568 | $32 |
| Erythromycin | 76 | $1,501 | $20 |
| Timolol Maleate | 71 | $1,263 | $18 |
| Brimonidine | 48 | $1,229 | $26 |
| Zymaxid | 11 | $1,143 | $104 |
| Doxycycline Hyclate | 12 | $1,080 | $90 |
| Dorzolamide-Timolol | 23 | $929 | $40 |
| Dorzolamide | 28 | $817 | $29 |
| Neomycin-Polymyxin-Dexameth | 25 | $505 | $20 |
| Bacitracin-Polymyxin | 17 | $434 | $26 |
| Levobunolol | 20 | $237 | $12 |
| Fluorometholone | 19 | $234 | $12 |
Money from drug and device companies
$25 in 2025
A payment is not proof that care is biased.
| Agios Pharmaceuticals | Pyrukynd | $25 | 1 payment
|
See the published payment
| Agios Pharmaceuticals | Meals · 2025-02-24 | Pyrukynd | $25 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366618290
- Licence
- CA A109727California A109727: Current · expires 2027-03-31
- Trained
- Stanford University School of Medicine, 2008
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 2452 Watson Ct, Palo Alto, CA, 94303
- NPI first listed
- 2008-04-30
- NPI last updated
- 2012-02-08
This is when the NPI record was last certified, not a medical board exam.